Many clinical studies indicate that TJ-43, co-administered with chemotherapy, improves anorexia and aids in maintaining food intake by mediating the 5-HT2B/C receptor or the ghrelin receptor [104,105,109,111,112,113,114,115,116,117]. This evidence concerns the gene GHSR and Anorexia.